Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Br J Ophthalmol ; 94(12): 1657-61, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20956272

RESUMEN

BACKGROUND: Conjunctival oedema is commonly observed in patients with allergic conjunctivitis and can be induced by histamine. In animal models of allergic conjunctivitis, conjunctival oedema is generally evaluated by measuring the extravasation of Evans blue dye into the conjunctiva. A limitation of this method is that it only allows evaluation at a single time point. The aim of the present study was to investigate kinetic changes in histamine-induced bulbar oedema. METHODS: Evans blue dye was injected intravenously into male guinea pigs. Histamine eye-drops were administered 30 min later. One group of animals received levocabastine (an antihistamine) eye-drops 10 min before histamine challenge. A digital camera was used to obtain images of the bulbar conjunctiva at 1 min intervals until 30 min after histamine challenge. The conjunctivas were then harvested, and the concentration of Evans blue was measured. The ImageJ software was used to analyse the images by counting the number of absolute pixel values. RESULTS: The degree of conjunctival oedema increased progressively until 20 min after histamine challenge and then stabilised. Correspondingly, the number of absolute pixel values increased significantly until 5 min after histamine challenge, then increased gradually until the 20 min time point and finally plateaued. Pixel values were significantly lower in animals treated with levocabastine than in control animals. A significant correlation was observed between the pixel values of the conjunctival images and the concentration of Evans blue in the conjunctiva. CONCLUSIONS: This is the first study to have quantitatively evaluated kinetic changes in histamine-induced bulbar oedema by means of image analysis.


Asunto(s)
Conjuntiva/patología , Conjuntivitis Alérgica/patología , Animales , Colorantes/administración & dosificación , Conjuntivitis Alérgica/inducido químicamente , Azul de Evans/administración & dosificación , Cobayas , Histamina , Agonistas de los Receptores Histamínicos , Procesamiento de Imagen Asistido por Computador , Masculino
2.
Jpn J Pharmacol ; 59(3): 267-74, 1992 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1434125

RESUMEN

Z-103 at 1 to 25 mg/kg, p.o. prevented 100% ethanol-induced gastric mucosal lesions in a dose-dependent manner. Z-103 at 3 to 25 mg/kg, p.o. significantly elevated gastric mucosal superoxide dismutase (SOD)-like activity 1 hr after its administration to normal rats. In addition, Z-103 at doses (10 and 25 mg/kg, p.o.) which prevented 100% ethanol-induced gastric lesion further increased gastric mucosal SOD-like and glutathione peroxidase (GSH-px) activities elevated by 60% ethanol. Z-103 (10 and 25 mg/kg) significantly inhibited the increase in thiobarbituric acid-reactive substances in gastric mucosa injured by 60% ethanol. The combination with cycloheximide, a protein synthesis inhibitor, completely abolished the prevention of 60% ethanol-induced gastric mucosal lesions and the elevation of both free radical scavenging enzyme activities in the mucosa by Z-103 (10 mg/kg, p.o.). These results suggest that Z-103 may partly protect rat gastric mucosa against ethanol-induced damage by scavenging oxygen-derived free radicals via increases in the synthesis of SOD-like and GSH-px enzymes in the mucosa.


Asunto(s)
Antiulcerosos/farmacología , Carnosina/análogos & derivados , Dipéptidos/farmacología , Depuradores de Radicales Libres , Mucosa Gástrica/enzimología , Glutatión Peroxidasa/metabolismo , Compuestos Organometálicos/farmacología , Superóxido Dismutasa/metabolismo , Zinc/farmacología , Administración Oral , Animales , Antiulcerosos/administración & dosificación , Dipéptidos/administración & dosificación , Relación Dosis-Respuesta a Droga , Etanol/toxicidad , Mucosa Gástrica/efectos de los fármacos , Masculino , Compuestos Organometálicos/administración & dosificación , Ratas , Ratas Endogámicas , Zinc/administración & dosificación , Compuestos de Zinc
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA